AVITA Medical, Inc. (ASX: AVH.AX) AI-Powered Stock Analysis
See how AVITA Medical, Inc. scores across key metrics like financial growth, valuation, and market position on the ASX, using AI-driven evaluation.
AVH.AX●ASX
HealthcareMedical - Devices
$4.55
$0.19(4.36%)
Australian Market opens in 53h 3m
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerAVITA Medical, Inc. (ASX: AVH.AX) Stock Overall Grade
AVITA Medical, Inc.'s grade for its ASX listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to AVITA Medical, Inc.'s overall ASX stock rating.
Forecast
C+Score
53/100Financial Growth
BScore
60/100Fundamental Growth
BScore
69/100Key Ratios
B+Score
70/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
94/100Analyst Consensus
C+Score
50/100AVITA Medical, Inc. (ASX: AVH.AX) AI-Powered Stock Analysis
On the ASX, AVH.AX demonstrates Good performance with an overall Forecast Score of 53/100 (C+), reflecting weak confidence in its potential. Financial Growth (60/100, B) and Fundamental Growth (69/100, B) highlight its stability, while Key Ratios (70/100, B+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (94/100, A+), the ASX-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(ASX: AVH.AX) Component Analysis Explained
Understand the key factors behind each AVITA Medical, Inc. (ASX: AVH.AX) stock grade, including financials, comparisons, and forecasts.